In vitro and in vivo analysis of B-Myb in basal-like breast cancer

Oncogene

Volumn 28, Issue 5, 2009, Pages 742-751

  Thorner, A R ^a,b   Hoadley, K A ^a,b   Parker, J S ^a   Winkel, S ^a,c   Millikan, R C ^a,c   Perou, C M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

B Myb; Basal like; Breast cancer; MYBL2

Indexed keywords

CAMPTOTHECIN; CARBOPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PACLITAXEL; PROTEIN B MYB; PROTEIN MYB; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL CYCLE REGULATION; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; ONCOGENE B MYB; ONCOGENE MYB; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; CELL CYCLE PROTEINS; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 59649114517     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.430     Document Type: Article

References (44)

1. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE et al. (2006). Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, Chromosomes Cancer 45: 1033-1040.
2. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F et al. (2007). The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13: 2329-2334.
3. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al. (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295: 2492-2502.
4. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo W-L et al. (2006). Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
5. Davidson CJ, Tirouvanziam R, Herzenberg LA, Lipsick JS. (2005). Functional evolution of the vertebrate Myb gene family: B-Myb, but neither A-Myb nor c-Myb, complements Drosophila Myb in hemocytes. Genetics 169: 215-229.
6. Derenzini M, Donati G, Mazzini G, Montanaro L, Vici M, Ceccarelli C et al. (2008). Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. Clin Cancer Res 14: 2199-2209.
7. Herschkowitz JI, He X, Fan C, Perou CM. (2008). The functional loss of the retinoblastoma tumor suppressor is a common event in basal-like and luminal B breast carcinomas. Breast Cancer Res 10: R75.
8. Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, Mejia JA et al. (2006). Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24: 4236-4244.
9. Hoadley K, Weigman V, Fan C, Sawyer L, He X, Troester M et al. (2007). EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics 8: 258.
10. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA. (2003). Identifying biological themes within lists of genes with EASE. Genome Biol 4(10): R70.
11. Hu Z, Fan C, Oh D, Marron J, He X, Qaqish B et al. (2006). The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7: 9 6.
12. Hu Z, Troester MA, Perou CM. (2005). High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays. Biotechniques 38: 121-124.
13. Ito M, Araki S, Matsunaga S, Itoh T, Nishihama R, Machida Y et al. (2001). G2/M-phase-specific transcription during the plant cell cycle is mediated by c-Myb-like transcription factors. Plant Cell 13: 1891-1905.
14. Klempnauer K-H, Gonda TJ, Bishop MJ. (1982). Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31: 453-463.
15. Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C et al. (1983). A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306: 395.
16. Malaterre J, Carpinelli M, Ernst M, Alexander W, Cooke M, Sutton S et al. (2007). c-Myb is required for progenitor cell homeostasis in colonic crypts. Proc Natl Acad Sci USA 104: 3829-3834.
17. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A et al. (2005). An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci 102: 13550-13555.
18. Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y et al. (2003). HER2 codon 655 polymorphism and risk of breast cancer in African Americans and Whites. Breast Cancer Res Treat 79: 355.
19. Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith K et al. (2008). Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123-139.
20. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA et al. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677.
21. Ness SA. (2003). Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol Dis 31: 192.
22. Newman B, Moorman P, Millikan R, Qaqish B, Geradts J, Aldrich T et al. (1995). The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35: 51-60.
23. Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S et al. (1988). Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res 16: 11075-11089.
24. Osterloh L, vonEyss B, Schmit F, Rein L, Hübner D, Samans B et al. (2007). The human synMuv-like protein LIN-9is required for transcription of G2/M genes and for entry into mitosis. EMBO J 26: 144-157.
25. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747.
26. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME et al. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436.
27. Rosinski JA, Atchley WR. (1998). Molecular evolution of the Myb family of transcription factors: evidence for polyphyletic origin. J Mol Evol 46: 74-83.
28. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K et al. (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11: 5678-5685.
29. Sala A. (2005). B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 41: 2479-2484.
30. Schwab R, Bussolari R, Corvetta D, Chayka O, Santilli G, Kwok JMM et al. (2007). Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk. Oncogene 27: 2929-2933.
31. Smith P, Soues S, Gottlieb T, Falk S, Watson J, Osborne R et al. (1994). Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br J Cancer 70: 914-921.
32. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874.
33. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423.
34. Tanaka Y, Patestos NP, Maekawa T, Ishii S. (1999). B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem 274: 28067-28070.
35. Toscani A, Mettus RV, Coupland R, Simpkins H, Litvin J, Orth J et al. (1997). Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature 386: 713.
36. Trauth K, Mutschler B, Jenkins N, Gilbert D, Copeland N, Klempnauer K. (1994). Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J 13: 5994-6005.
37. Troester MA, Hoadley KA, Sorlie T, Herbert B-S, Borresen-Dale A-L, Lonning PE et al. (2004). Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 64: 4218-4226.
38. Tusher VG, Tibshirani R, Chu G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
39. van de Vijver MJ, He YD, van 't Veer LJ, Dai H, Hart AAM, Voskuil DW et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
40. Vanewijk PH, Hoekstra JA. (1993). Calculation of the EC50 and its confidence interval when subtoxic stimulus is present. Ecotoxicol Environ Saf 25: 25.
41. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671.
42. Whitfield ML, George LK, Grant GD, Perou CM. (2006). Common markers of proliferation. Nat Rev Cancer 6: 99-106.
43. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE et al. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13: 1977-2000.
44. Zhu W, Giangrande PH, Nevins JR. (2004). E2Fs link the control of G1/S and G2/M transcription. EMBO J 23: 4615-4626.